Sign Up | Log In | What is SocialPicks?

Dynavax Technologies Corp. (DVAX) Trade Now » Rate DVAX - Discuss DVAX - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

82.0%

Top:

0.0%

Rate DVAX:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

DVAX Analysis & Videos »

... View All >

DVAX: Bull or Bear?

Dynavax Technologies Corp. DVAX

N/A

-5.80%
in 9 days

Last trade signal was SELL
at 2008-Dec-22
Price: $0.97

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Our clinical development programs are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic in...

Continue reading »

By supratrader (+2.48% risk: conservative) 06/27/09

Comment

Bullish on DVAX ... DVAX

62%

-29.63%
in 33 days

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops a diversified pipeline of Toll-like Receptor (TLR) product candidates primarily in the United States. Based on Dynavax?s proprietary technology platform, these products specifically modify the innate immune response to infectious, respiratory, autoimmune, and inflammatory diseases. The company?s product programs are supported by global partnerships with pharmaceutical companies, such as GlaxoSmithKline, AstraZeneca AB, and Novartis Vaccines and Diagnostics, Inc, as well as funding from Symph...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 06/03/09

Comment

hay hay hay DVAX

N/A

+0.00%
in 0 minute
(closed on 06/03/09)

mite make me a dollar hear

Continue reading »

By jay pollard (-2.60% risk: conservative) 06/03/09

Comment

Clinical Hold on Dynavax Drug DVAX

-12.75%
in 360 days

We are intrigued by DynavaxÂ?s proprietary ImmunoStimulatory Sequence technology, but disappointed with the clinical hold on its lead candidate Heplisav. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was added on experimental basis to see the effect. This part was a...

Continue reading »

By Zacks.com (-19.65% risk: moderate) 07/10/08

Comment

... View All >

People Bullish on DVAX

supratrader

Principal

N/A

8 days ago

Marian Filo

Principal

62%

about 1 mo ago

jay pollard

Associate

N/A

about 1 mo ago

buster66

Analyst

62%

4 mos ago

markesteele

Analyst

N/A

7 mos ago

People Bearish on DVAX

crispy

Sr. Associate

74%

over 2 years ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+42.40%	271
2	Gerald Greene	18.14	+59.31%	139
3	stockmarketfunding.com	17.66	+22.00%	34
4	akiralegrand	13.47	+15.91%	48
5	anup2104	12.13	+37.83%	12

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
FNM	Fannie Mae
PFE	Pfizer Inc
LEH	Lehman Brothers Holdings Inc
AAPL	Apple Computer Inc
WM	Washington Mutual Inc
INTC	Intel Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

APPY		Extreme FDA Medical Device Trades: 7 Stocks Under $5 by Mike Havrilla
ARYX		Extreme FDA Calendar Trades: 18 Stocks Under $5 by Mike Havrilla
DGX		Quest Diagnostics Inc. by Marian Filo
LNC		Accepting TARP is a VERY bad sign by utopius
KG		FDA Calendar Updates: ACUR, KG, MYRX, NEPH, Eisai by Mike Havrilla

... more »

StreetInsider.com on DVAX

Form 4 LAMPERT MARK N For: Jun 19

Form 4 Plotkin Stanley A For: May 13

Form 4 DYNAVAX TECHNOLOGIES For: May 13 Filed by: ORONSKY ARNOLD L

Form 4 DYNAVAX TECHNOLOGIES For: May 13 Filed by: LAWRENCE DAVID M

Form 4 DYNAVAX TECHNOLOGIES For: May 13 Filed by: CARSON DENNIS

Discussion Wall

+ Add

jay pollard (-2.60% risk: conservative)

my pick of the day - maybe maybe not???????????

+	0 replies

... more »

More Resources

About Dynavax Technologies Corp. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.